SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001654954-20-000350
Filing Date
2020-01-13
Accepted
2020-01-13 10:11:48
Documents
1
Period of Report
2020-01-08

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT section16.html 4/A  
1 PRIMARY DOCUMENT section16.xml 4/A 17122
  Complete submission text file 0001654954-20-000350.txt   19157
Mailing Address 100 SPY COURT MARKHAM A6 L3R 5H6
Business Address 100 SPY COURT MARKHAM A6 L3R 5H6 (905) 475-1234
Edesa Biotech, Inc. (Issuer) CIK: 0001540159 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations

Mailing Address 141 ADELAIDE STREET WEST SUITE 770 TORONTO A6 M5H 3L5
Business Address 141 ADELAIDE STREET WEST SUITE 770 TORONTO A6 M5H 3L5 416-213-4223
Lumira Capital Investment Management Inc. (Reporting) CIK: 0001702636 (see all company filings)

State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 4/A | Act: 34 | File No.: 001-37619 | Film No.: 20523082

Mailing Address C/O EDESA BIOTECH INC. 100 SPY COURT MARKHAM A6 L3R 5H6
Business Address
van der Velden Peter (Reporting) CIK: 0001778046 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-37619 | Film No.: 20523083